Informations Presse

Au quatrième trimestre, Philips a inscrit une croissance du chiffre d'affaires comparable de 2% à 7,1 milliards EUR et une amélioration de l'EBITA corrigé de 13% à 842 millions EUR

janvier 26, 2016

Faits marquants du quatrième trimestre 
  • Le chiffre d'affaires comparable a augmenté de 2%, surtout en raison d'une croissance de 4% du portefeuille HealthTech.
  • En données corrigées des effets de change, le carnet de commandes s'est étoffé de 15%, principalement grâce à l'Amérique du Nord, la Chine et l'Europe occidentale.
  • L'EBITA corrigé1) a gagné 50 points de base pour atteindre 11,9% du chiffre d'affaires, soit 842 millions EUR.
  • L'EBITA s'élevait à 263 millions EUR, soit 3,7% du chiffre d'affaires
  • Une perte nette de 39 millions EUR causée par des charges uniques, dont l'abandon annoncé précédemment des risques en matière de pension, pour un bénéfice net de 134 millions EUR au quatrième trimestre 2014.
  • Les flux de trésorerie disponibles se sont chiffrés à 740 millions EUR, contre 559 millions EUR au quatrième trimestre 2014.
  • La scission de Philips Lighting suit son cours.

Faits marquants de l'année entière
  • Le chiffre d'affaires comparable a augmenté de 2% pour atteindre 24,2 milliards EUR, surtout en raison d'une croissance de plus de 4% du portefeuille HealthTech.
  • En données corrigées des effets de change, le carnet de commandes s'est étoffé de 5%, principalement grâce à l'Amérique du Nord et l'Europe occidentale.
  • L'EBITA corrigé a gagné 20 points de base pour atteindre 9,2% du chiffre d'affaires, soit 2,2 milliards EUR.
  • L'EBITA a atteint 1,4 milliard EUR, soit 5,7% du chiffre d'affaires, contre 821 millions EUR (3,8% du chiffre d'affaires) en 2014.
  • Le résultat net s'est élevé à 659 millions EUR, contre 411 millions EUR en 2014.
  • Les flux de trésorerie disponibles se sont chiffrés à 325 millions EUR, contre 497 millions EUR en 2014.
  • Le rendement du capital investi atteint désormais 7,0%, contre 4,5% en 2014.
  • Proposition de maintenir le dividende à 0,80 EUR par action.


Frans van Houten, CEO :
"Au quatrième trimestre 2015 aussi, Philips a amélioré ses résultats d'exploitation par rapport à la période correspondante de 2014. Nous avons réalisé une progression de l'EBITA corrigé dans les trois secteurs et les activités opérationnelles ont généré des flux de trésorerie de près de 1 milliard EUR.

Au quatrième trimestre, nous avons assisté à une reprise de la croissance du chiffre d'affaires de Healthcare. En données corrigées des effets de change, le carnet de commandes a enregistré une forte croissance (15%), et les marges se sont elles aussi améliorées par rapport à la période correspondante de 2014. Chez Consumer Lifestyle, nous avons à nouveau enregistré une solide croissance de tous les composants, et notamment chez Health & Wellness, alors que des améliorations de la productivité et de la gamme ont débouché sur des marges nettement plus élevées. Lighting a encore amélioré ses résultats par rapport à la période correspondante de l'année passée. C'est entre autres la conséquence d'une croissance soutenue du chiffre d'affaires comparable et d'une amélioration des marges des activités LED, ainsi que de nos mesures efficaces visant à compenser le déclin du marché des produits d'éclairage conventionnels.

Globalement, Philips a réalisé de solides performances en 2015. Ceci se traduit par des améliorations cohérentes des résultats, alors que les circonstances macroéconomiques restent difficiles. Lighting a à nouveau amélioré ses résultats d'exploitation. Notre portefeuille HealthTech, qui se compose de Healthcare et de Consumer Lifestyle, a réalisé une croissance prometteuse du chiffre d'affaires comparable, qui a dépassé 4% sur l'année entière. Nous sommes donc mieux en mesure de profiter des possibilités qu'offre ce marché de grande envergure et en plein essor. La croissance de 5% du volume de commandes de Healthcare est encourageante.

Pour 2016, nous tablons sur une croissance modeste du chiffre d'affaires comparable et nous poursuivrons sur la voie de l'amélioration de nos résultats d'exploitation sur 2015. Compte tenu de la persistance des aléas macroéconomiques et de l'étalement des frais et du chiffre d'affaires sur l'année, nous prévoyons que les améliorations soient perceptibles au second semestre 2016."
 

1) L'EBITA corrigé est le résultat d'exploitation (EBIT) hors amortissements sur actifs incorporels acquis, variations de valeur particulières du goodwill et d'autres actifs incorporels, charges de restructuration, frais liés aux reprises et autres postes exceptionnels.

Click here to view the release online

Communiqué de presse

Philips launched the new range of Efficia patient monitors in Tanzania

Philips launched the new range of Efficia patient monitors in Tanzania

Expanding its portfolio of healthcare solutions for low-resource countries, Philips launched the new range of Efficia patient monitors in Tanzania for the delivery of high-quality care at affordable cost, even in remote areas. Moreover, Philips developed a new diagnostic device to help improve the diagnosis and treatment of pneumonia in countries such as Tanzania.

UCHealth deploys Philips IntelliSpace PACS to optimize its image sharing workflow, driving cost savings and enhancing patient care

UCHealth deploys Philips IntelliSpace PACS to optimize its image sharing workflow, driving cost savings and enhancing patient care

Philips and UCHealth, an integrated delivery network (IDN) in Colorado, USA, signed a multi-year agreement for the implementation of Philips’ IntelliSpace Picture Archiving and Communications Systems across the IDN to optimize its image sharing workflow, thereby enhancing patient care and driving projected USD 11 million cost savings over five years.

 Philips was leading brand on ‘double 11’

Philips was leading brand on ‘double 11’

On China’s biggest day for online shopping, ‘double 11’, Philips was a leading brand in categories like Male Grooming, Beauty, Garment Care, Kitchen Appliances and Oral Healthcare, with some product ranges selling out within minutes. Male shaving products were particularly popular, with over half a million Philips shavers sold in 24 hours.

Oral Healthcare experienced double-digit growth

Oral Healthcare experienced double-digit growth

Oral Healthcare experienced double-digit growth, with very strong performance in North America, China and Germany, Austria & Switzerland. The Philips Sonicare 2 electric toothbrush range was cited by US retailer Target as one of the most popular items in their Black Friday pre-sale.

Philips and City of San Jose partner to deploy Philips SmartPoles pilot project

Philips and City of San Jose partner to deploy Philips SmartPoles pilot project

Building on the company’s leadership in connected lighting, Philips entered into a global strategic alliance with Cisco to address the growing worldwide office market. Integrating Philips’ connected LED lighting system with Cisco’s IT network will save energy, improve building efficiency, and enhance employee well-being and productivity.

Philips and City of San Jose partner to deploy Philips SmartPoles pilot project combining energy efficient LED street lighting with wireless broadband technology from Ericsson

Philips and City of San Jose partner to deploy Philips SmartPoles pilot project combining energy efficient LED street lighting with wireless broadband technology from Ericsson

Expanding on Philips’ smart street lighting offering, Los Angeles and San Jose are the first cities to benefit from Philips LED street lighting combined with wireless broadband technology from Ericsson. Philips SmartPoles will expand wireless broadband coverage, reduce energy usage by more than 50%, and provide brighter, safer streets at night.

Philips and Banyan Biomarkers partner to develop and commercialize new handheld blood test to detect and evaluate concussions

Philips and Banyan Biomarkers partner to develop and commercialize new handheld blood test to detect and evaluate concussions

Philips and Banyan Biomarkers entered into a joint development agreement to develop and commercialize a new handheld blood test to detect concussion. The partnership will broaden the application of Philips’ handheld diagnostics system and will strengthen its competitive position in pointof-care diagnostics for acute care settings, a new growth market for Philips.

Philips adds Ledra Brands as its 600th member to its industry leading EnabLED Licensing Program for LED Luminaires and Retrofit Bulbs

Philips adds Ledra Brands as its 600th member to its industry leading EnabLED Licensing Program for LED Luminaires and Retrofit Bulbs

Philips welcomed the 600th member to its LED Luminaires and Retrofit Bulbs Licensing Program, which gives licensees access to its wide portfolio of patented LED system technologies and solutions. Philips has fostered the adoption of LED technology and LED industry growth through the licensing program since its inception in 2008.

Pour plus d’informations, veuillez contacter :

Steve Klink 
Philips Group Communications
Tel: +31 6 10888824
E-mail: steve.klink@philips.com 

Joost Akkermans
Philips Group Communications
Tel.: +31 6 3175 8996
E-mail: joost.akkermans@philips.com 
.

A propos de Royal Philips :

Royal Philips (NYSE : PHG, AEX : PHIA) se pose comme une entreprise diversifiée, active dans les domaines « de la Santé et du Bien-être » et qui a pour but d’améliorer la qualité de vie des personnes par des innovations significatives dans les domaines des soins de santé, de la vie moderne et de l’éclairage. Philips, dont le siège social se trouve aux Pays- Bas, emploie quelque 106.000 personnes actives dans les domaines de la vente et des services dans plus de 100 pays et a réalisé un chiffre d’affaires de 21,4 milliards d’euros en 2014. L’entreprise est leader sur les marchés des soins cardiologiques, des soins de médecine d’urgence et des soins de santé à domicile, des solutions d’éclairage économique et des nouvelles solutions d’éclairage ainsi que dans le domaine des rasoirs électriques et des soins d’hygiène dentaire. Vous trouverez plus de renseignements sur Philips via www.philips.com/newscenter.  .

Forward-looking statements

This document and the related oral presentation, including responses to questions following the presentation, contain certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. Examples of forward-looking statements include statements made about the strategy, estimates of sales growth, future EBITA, future developments in Philips’ organic business and the completion of acquisitions and divestments. By their nature, these statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these statements.

These factors include but are not limited to domestic and global economic and business conditions, developments within the euro zone, the successful implementation of Philips’ strategy and the ability to realize the benefits of this strategy, the ability to develop and market new products, changes in legislation, legal claims, changes in exchange and interest rates, changes in tax rates, pension costs and actuarial assumptions, raw materials and employee costs, the ability to identify and complete successful acquisitions, including Volcano, and to integrate those acquisitions into the business, the ability to successfully exit certain businesses or restructure the operations, the rate of technological changes, political, economic and other developments in countries where Philips operates, industry consolidation and competition. As a result, Philips’ actual future results may differ materially from the plans, goals and expectations set forth in such forward-looking statements. For a discussion of factors that could cause future results to differ from such forward-looking statements, see the Risk management chapter included in the Annual Report 2014 and the “Risk and uncertainties” section in the semi-annual financial report for the six months ended June 30, 2015.

Third-party market share data
Statements regarding market share, including those regarding Philips’ competitive position, contained in this document are based on outside sources such as research institutes, industry and dealer panels in combination with management estimates. Where information is not yet available to Philips, those statements may also be based on estimates and projections prepared by outside sources or management. Rankings are based on sales unless otherwise stated.

Use of non-GAAP information
In presenting and discussing the Philips Group financial position, operating results and cash flows, management uses certain non-GAAP financial measures. These non-GAAP financial measures should not be viewed in isolation as alternatives to the equivalent IFRS measures and should be used in conjunction with the most directly comparable IFRS measures. Non-GAAP financial measures do not have standardized meaning under IFRS and therefore may not be comparable to similar measures presented by other issuers. A reconciliation of these non-GAAP measures to the most directly comparable IFRS measures is contained in this document. Further information on non-GAAP measures can be found in the Annual Report 2014.

Use of fair-value measurements
In presenting the Philips Group financial position, fair values are used for the measurement of various items in accordance with the applicable accounting standards. These fair values are based on market prices, where available, and are obtained from sources that are deemed to be reliable. Readers are cautioned that these values are subject to changes over time and are only valid at the balance sheet date. When quoted prices or observable market data are not readily available, fair values are estimated using appropriate valuation models and unobservable inputs. Such fair value estimates require management to make significant assumptions with respect to future developments, which are inherently uncertain and may therefore deviate from actual developments. Critical assumptions used are disclosed in the Annual Report 2014. Independent valuations may have been obtained to support management’s determination of fair values.

Presentation
All amounts are in millions of euros unless otherwise stated. All reported data is unaudited. Financial reporting is in accordance with the accounting policies as stated in the Annual Report 2014, unless otherwise stated. The presentation of certain prior-year information has been reclassified to conform to the current-year presentation. In 2014, we announced plans to establish two standalone companies focused on the HealthTech and Lighting opportunities. The proposed separation of the Lighting business impacts all businesses and markets as well as all supporting functions and all assets and liabilities of the Group. Philips expects to complete the separation of the Lighting business in the first half of 2016. We expect to continue reporting in the existing structure until the changes in the way we allocate resources and analyze performance in the new structure have been completed..